by Garth Sundem | Jan 30, 2020 | Featured, Research
Ashley Glode, PharmD Chemotherapy used to shrink a tumor before surgery, called neoadjuvant chemotherapy, is becoming more common in many cancers, including stage II and III rectal cancer. However, the chemotherapy regimens FOLFOX and CapeOx used in this setting come...
by Garth Sundem | Apr 3, 2019 | Featured, Latest News, Research
The chemotherapy drug irinotecan creates DNA damage leading to cell death and is used to treat colorectal cancer, among other cancer types. Now a University of Colorado Cancer Center study presented at the American Association for Cancer Research (AACR) Annual Meeting...
by Taylor Abarca | Mar 29, 2019 | Featured, Latest News, Research
More and more young people are being diagnosed with colorectal cancer. The increase is not small—the number of cases is up approximately 40 percent in the last 25 years. This is a stark contrast to the decrease of 40 percent in populations typically affected by...
by Taylor Abarca | Mar 22, 2019 | Featured, Patient Care
Diagnosed with stage 3 colorectal cancer at just 38 years old, Jimmy Zannon was a far cry from the “typical” patient. Colorectal cancer was once (and often is still) considered a disease of the elderly. With the average age of diagnosis being 68 in men and 72 in...
by Taylor Abarca | Mar 14, 2019 | Featured, Latest News, Patient Care, Research
Colorectal cancer is unique in that, unlike many other cancers, we know how it progresses from healthy to cancerous. We also know how to prevent it and catch it in its early stages, making it one of the only truly preventable cancers. Unfortunately, even with this...
